Nextern Innovation LLC recently secured a major technological breakthrough with the issuance of U.S. Patent No. US12776413B2. This patent, titled ‘Self-validating module for software control of medical devices’, introduces a powerful way to ensure safety in connected healthcare equipment. Inventors Ryan J. Douglas and Jonathan Lawson have developed a system that validates control signals from third party software before they reach critical medical devices.
MINNESOTA PATENT OF THE MONTH – NOVEMBER 2026
The innovation focuses on a safety module that acts as a secure gatekeeper for medical equipment. This system uses advanced validation routines to authenticate incoming commands from smart devices. A specialized electronic module within the device processes these signals. This module is configured to isolate critical medical functions from unverified external inputs. A precision validation algorithm ensures the software control remains reliable and secure. This setup allows for incredible accuracy and safety during patient care.
Recognized for Innovation by Swanson Reed
Traditional methods often struggle to maintain secure communication between medical devices and consumer electronics. However, this self-validating module creates a robust verification process for every interaction. This technology eliminates common vulnerabilities in software control safety. It helps healthcare providers manage patient health without the risk of software malfunctions or unauthorized access. The system remains compact and efficient for integration into modern medical devices. This advancement will likely transform safety standards in the medical technology industry, which is why it was awarded the Minnesota Patent of the Month for November 2026 by Swanson Reed. The firm recognized the invention for its ability to overcome significant technical uncertainties and deliver exceptional technical advancement in the field of medical device security.
Eligibility for R&D Tax Credits
The practical applications of this patent present strong opportunities for claiming the Research and Development (R&D) tax credit in the USA. Companies engineering similar self-validating systems must overcome significant technical uncertainties related to software integration and hardware reliability. The iterative development process required to design, test, and refine these validation algorithms constitutes qualified research under IRC Section 41. Businesses can claim R&D tax credits for the wages, supplies, and contractor costs associated with developing these secure communication protocols. By improving the performance and safety of medical devices, developers meet the permitted purpose requirements necessary to benefit from these important financial incentives.
